2226: Hemogenyx CEO on positive progress with leukemia drug
Update: 2025-10-30
Description
Watch on YouTube
Hemogenyx #HEMO has been given clearance to proceed with the next stage of testing in regard to its HG-CT1 therapy, which is designed to treat leukemia. Hemogenyx's chief executive Vladislav Sandler joins us to talk about the implications of continuing the trials, how they will be structured, and widened with the addition of testing for a group of 12-18 year olds.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
